View of Role of molecular examinations in qualification to first line treatment with erlotinib in NSCLC patients based on EUTARCstudy results

Return to Article Details Role of molecular examinations in qualification to first line treatment with erlotinib in NSCLC patients based on EUTARCstudy results Download Download PDF